<unk> , sold under the brand name Mycamine, is a echinochandin antifungal medication used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls.<unk>  is administered intravenously. It received final approval from the U.S. Food and Drug Administration (FDA) in March 2005, and gained approval in the European Union in April 2008. It is on the World Health Organization's List of Essential Medicines.
Micafungin
Caspofungin
Anidulafungin
Fluconazole
Itraconazole
Miconazole
Terbinafine
Sertaconazole